Ms. Zhu never imagined that at the age of 84, she would undergo such a "record-breaking" surgery. Doctors removed her entire pancreas, spleen, and gallbladder, reconstructed her gastrointestinal tract and blood vessels, and simultaneously performed an autologous islet transplantation.

Lu Daopei Hospital's dual-target CAR-T saves critically ill international DLBCL patient! A 60-year-old Egyptian with massive abdominal tumor & TP53 mutations achieved remarkable recovery after CD19/CD22 CAR-T + radiotherapy. From unable to sit to walking out smiling.

Recently, the international hematology journal Blood Advances published a prospective clinical study by Lu Daopei Medical Team, titled "Efficacy and safety of BCMA nanobody CAR T-cell therapy in relapsed or refractory plasma cell myeloma," reporting breakthrough clinical results of BCMA-targeted nanobody-based CAR-T cell therapy in heavily pretreated refractory/relapsed plasma cell neoplasms.

China's Top 10 General Surgery Hospitals In 2023 Fudan Rankings，Peking Union Medical College Hospital Got Top One

Doctor Guide: Meet Dr. Song Donglei A Pioneer in Neurosurgery at Shanghai Donglei Brain Hospital | China Medical Tourism | China Hospital | China Medical Treatment | Donglei Brain Hospital | Nerosurgery